| Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort study SC Gouw, JG van der Bom, H Marijke Van Den Berg Blood, The Journal of the American Society of Hematology 109 (11), 4648-4654, 2007 | 645 | 2007 |
| Factor VIII products and inhibitor development in severe hemophilia A SC Gouw, JG Van Der Bom, R Ljung, C Escuriola, AR Cid, ... New England Journal of Medicine 368 (3), 231-239, 2013 | 521 | 2013 |
| F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis SC Gouw, HM van den Berg, J Oldenburg, J Astermark, PG de Groot, ... Blood, The Journal of the American Society of Hematology 119 (12), 2922-2934, 2012 | 423 | 2012 |
| Intensity of factor VIII treatment and inhibitor development in children with severe hemophilia A: the RODIN study SC Gouw, HM van den Berg, K Fischer, G Auerswald, M Carcao, ... Blood, The Journal of the American Society of Hematology 121 (20), 4046-4055, 2013 | 375* | 2013 |
| Recombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A: the CANAL cohort study SC Gouw, JG van der Bom, G Auerswald, CE Ettinghausen, U Tedgård, ... Blood, The Journal of the American Society of Hematology 109 (11), 4693-4697, 2007 | 338 | 2007 |
| Treatment characteristics and the risk of inhibitor development: a multicenter cohort study among previously untreated patients with severe hemophilia A SC Gouw, HM Van Den Berg, S Le Cessie, JG Van Der Bom Journal of Thrombosis and Haemostasis 5 (7), 1383-1390, 2007 | 185 | 2007 |
| The multifactorial etiology of inhibitor development in hemophilia: genetics and environment SC Gouw, HM van den Berg Seminars in thrombosis and hemostasis 35 (08), 723-734, 2009 | 150 | 2009 |
| IgG subclasses of anti‐FVIII antibodies during immune tolerance induction in patients with hemophilia A PMW van Helden, HM van den Berg, SC Gouw, PHP Kaijen, MG Zuurveld, ... British journal of haematology 142 (4), 644-652, 2008 | 113 | 2008 |
| Core outcome set for gene therapy in haemophilia: results of the core HEM multistakeholder project A Iorio, MW Skinner, E Clearfield, D Messner, GF Pierce, M Witkop, ... Haemophilia 24 (4), e167-e172, 2018 | 89 | 2018 |
| Correlation between phenotype and genotype in a large unselected cohort of children with severe hemophilia A MD Carcao, HM van den Berg, R Ljung, ME Mancuso, C Altisent, ... Blood, The Journal of the American Society of Hematology 121 (19), 3946-3952, 2013 | 78 | 2013 |
| Choosing outcome assessment tools in haemophilia care and research: a multidisciplinary perspective K Fischer, P Poonnoose, AL Dunn, P Babyn, MJ Manco‐Johnson, ... Haemophilia 23 (1), 11-24, 2017 | 76 | 2017 |
| Mortality, life expectancy, and causes of death of persons with hemophilia in the Netherlands 2001–2018 S Hassan, RC Monahan, EP Mauser‐Bunschoten, LFD van Vulpen, ... Journal of Thrombosis and Haemostasis 19 (3), 645-653, 2021 | 73 | 2021 |
| Cost-effectiveness and budget impact of emicizumab prophylaxis in haemophilia A patients with inhibitors PA Cortesi, G Castaman, G Trifirò, SS Creazzola, G Improta, G Mazzaglia, ... Thrombosis and Haemostasis 120 (02), 216-228, 2020 | 66 | 2020 |
| Influence of the type of F8 gene mutation on inhibitor development in a single centre cohort of severe haemophilia A patients SC Gouw, JG Van Der Bom, HM Van Den Berg, RA Zewald, ... Haemophilia 17 (2), 275-281, 2011 | 64 | 2011 |
| Health‐related quality of life questionnaires in individuals with haemophilia: a systematic review of their measurement properties PF Limperg, CB Terwee, NL Young, VE Price, SC Gouw, M Peters, ... Haemophilia 23 (4), 497-510, 2017 | 63 | 2017 |
| Measurement of joint health in persons with haemophilia: a systematic review of the measurement properties of haemophilia‐specific instruments SC Gouw, MA Timmer, A Srivastava, P de Kleijn, P Hilliard, M Peters, ... Haemophilia 25 (1), e1-e10, 2019 | 51 | 2019 |
| Similar bleeding phenotype in young children with haemophilia A or B: a cohort study N Clausen, P Petrini, S Claeyssens‐Donadel, SC Gouw, R Liesner, ... Haemophilia 20 (6), 747-755, 2014 | 46 | 2014 |
| Vaccinations are not associated with inhibitor development in boys with severe haemophilia A H Platokouki, K Fischer, SC Gouw, A Rafowicz, M Carcao, G Kenet, ... Haemophilia 24 (2), 283-290, 2018 | 39 | 2018 |
| Incidence and mortality rates of intracranial hemorrhage in hemophilia: a systematic review and meta-analysis AF Zwagemaker, SC Gouw, JS Jansen, C Vuong, M Coppens, Q Hu, ... Blood, The Journal of the American Society of Hematology 138 (26), 2853-2873, 2021 | 37 | 2021 |
| Measuring activities and participation in persons with haemophilia: a systematic review of commonly used instruments MA Timmer, SC Gouw, BM Feldman, A Zwagemaker, P De Kleijn, ... Haemophilia 24 (2), e33-e49, 2018 | 37 | 2018 |
